MAY 26, 2015 06:00 AM PDT

Cell-Imaging and Luminescence Based Cytotoxicity Analysis using the EnSight Multimode Plate Reader

Speakers
  • Application Specialist, PerkinElmer
    Biography
      Frauke Haenel studied Biology and achieved her PhD in 2011 at the University of Kassel, Germany. She joined PerkinElmer in May 2011 as part of the application support team based in Hamburg, Germany. The team provides support for the Multimode Detection Plate Readers to customers, sales and service. Within this team, Frauke mainly focuses on providing assistance on imaging and label-free applications, including trainings and application development.
    • Chief Scientific Officer, Fraunhofer IME, Hamburg, Germany
      Biography
        Dr. Philip Gribbon is the Chief Scientific Officer at the Fraunhofer IME, a public-private partnership based in Hamburg Germany, which works mainly with academic research institutes in the area of drug discovery. The ESP uses a range of high throughput screening (HTS) systems and assay methods and provides support for biomarker studies within clinical and pre-clinical research projects. Since the setup of the ESP, Dr. Gribbon has worked in close collaboration with leading life-science industry partners, such as PerkinElmer, to help validate novel technologies which can directly apply to projects. Previously, Dr. Gribbon has worked at Pfizer Global Research on hit discovery using HTS technologies and gained considerable experience in drug discovery across several target classes. Later, at GSK, he led a team of physicists with the remit of increasing the impact of biophysical methods on the pharmaceutical R&D process. Dr. Gribbon did his undergraduate and PhD studies at Imperial College, London and served as a post-doctoral researcher at the University of Manchester, working on how the biophysical properties of proteoglycans help define the mechanical properties of cartilage in health and disease.

      Abstract:

      Sign up here to watch this Webinar On Demand


      Cytotoxicity remains one of the major causes of drug withdrawal and there is an urgent need for reliable and time-saving assay workflows. Cells exposed to toxic compounds show a variety of phenotypes including the loss of membrane integrity, cell shrinkage and nuclear fragmentation. These are ideal effects to be analyzed using cell imaging in addition to conventional cytotoxicity assays.


       In the first part of this webinar, we will give you an overview of the EnSight™ Multimode Plate Reader with Well-Imaging Technology and its capabilities to analyze multiple parameters of cytotoxicity on the same sample using the Kaleido™ Data Acquisition and Analysis Software. In the second part of the webinar, we will show a real life application of both anti-cancer drug discovery and in-vitro toxicity testing. You will see how to determine the compound effects on cellular viability and proliferation by comparing the use of brightfield imaging and ATP detection.


       During this webinar, you will:


      -        Learn about the EnSight system’s capabilities to detect cytotoxicity using multiple parameters


      -        Get insight into automated image analysis using the Kaleido software


      -        See how live cell imaging can provide additional information and save you time and money


      -        Have your questions answered live


      Show Resources
      You May Also Like
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      SEP 05, 2019 04:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      JUN 19, 2019 10:00 AM PDT
      JUN 19, 2019 10:00 AM PDT
      DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
      Loading Comments...
      Show Resources